Metabolomics kan potentielt forbedre lægemiddelterapien

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Metabolomics kan potentielt forbedre lægemiddelterapien. / Stage, Claus; Jürgens, Gesche; Dalhoff, Kim Peder; Rasmussen, Henrik Berg.

I: Ugeskrift for Laeger, Bind 176, Nr. 6, V02130127, 17.03.2014, s. 525-528.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Stage, C, Jürgens, G, Dalhoff, KP & Rasmussen, HB 2014, 'Metabolomics kan potentielt forbedre lægemiddelterapien', Ugeskrift for Laeger, bind 176, nr. 6, V02130127, s. 525-528.

APA

Stage, C., Jürgens, G., Dalhoff, K. P., & Rasmussen, H. B. (2014). Metabolomics kan potentielt forbedre lægemiddelterapien. Ugeskrift for Laeger, 176(6), 525-528. [V02130127].

Vancouver

Stage C, Jürgens G, Dalhoff KP, Rasmussen HB. Metabolomics kan potentielt forbedre lægemiddelterapien. Ugeskrift for Laeger. 2014 mar. 17;176(6):525-528. V02130127.

Author

Stage, Claus ; Jürgens, Gesche ; Dalhoff, Kim Peder ; Rasmussen, Henrik Berg. / Metabolomics kan potentielt forbedre lægemiddelterapien. I: Ugeskrift for Laeger. 2014 ; Bind 176, Nr. 6. s. 525-528.

Bibtex

@article{9c8d7c921fef47c09431f1c15a522404,
title = "Metabolomics kan potentielt forbedre l{\ae}gemiddelterapien",
abstract = "Until now drug therapy has primarily been controlled by dose titration on the basis of effects and side effects. However, a lot of people being treated with a drug experience too little effect or too many side effects. Therefore it will be advantageous to improve drug therapy and make it even more {"}individualized{"}. In this chase metabolomics is a hot topic. The aim of this paper is to review the concepts of metabolomics and the possible applications in regard to drug development, drug therapy and diagnosis, prognosis and monitoring of diseases.",
author = "Claus Stage and Gesche J{\"u}rgens and Dalhoff, {Kim Peder} and Rasmussen, {Henrik Berg}",
year = "2014",
month = mar,
day = "17",
language = "Dansk",
volume = "176",
pages = "525--528",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "6",

}

RIS

TY - JOUR

T1 - Metabolomics kan potentielt forbedre lægemiddelterapien

AU - Stage, Claus

AU - Jürgens, Gesche

AU - Dalhoff, Kim Peder

AU - Rasmussen, Henrik Berg

PY - 2014/3/17

Y1 - 2014/3/17

N2 - Until now drug therapy has primarily been controlled by dose titration on the basis of effects and side effects. However, a lot of people being treated with a drug experience too little effect or too many side effects. Therefore it will be advantageous to improve drug therapy and make it even more "individualized". In this chase metabolomics is a hot topic. The aim of this paper is to review the concepts of metabolomics and the possible applications in regard to drug development, drug therapy and diagnosis, prognosis and monitoring of diseases.

AB - Until now drug therapy has primarily been controlled by dose titration on the basis of effects and side effects. However, a lot of people being treated with a drug experience too little effect or too many side effects. Therefore it will be advantageous to improve drug therapy and make it even more "individualized". In this chase metabolomics is a hot topic. The aim of this paper is to review the concepts of metabolomics and the possible applications in regard to drug development, drug therapy and diagnosis, prognosis and monitoring of diseases.

M3 - Tidsskriftartikel

C2 - 25096206

VL - 176

SP - 525

EP - 528

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 6

M1 - V02130127

ER -

ID: 137669072